Quiet Lab Mouthpiece officially launches in the USA, UK, Canada & Australia — a breakthrough quietlab anti-snoring and ...

Nyxoah announced today that it closed a series of financings that amount to up to approximately $77 million in proceeds.

ResMed faces an uncertain future as GLP-1 weight loss drugs threaten to reduce demand for sleep apnea devices, creating a complex investment dilemma for shareholders of the CPAP machine leader.

Also, Topcon acquires New Zealand-founded Toku to expand access to AI-based health screening using retinal images.

Glancy Prongay & Murray LLP, a leading national shareholder rights law firm, announces that a securities fraud class action lawsuit has been filed on behalf of investors who purchased or otherwise ...

In "Don't Sleep on OSA," O'Neal discusses symptoms like "breathing interruptions during sleep... and daytime fatigue." ...

IF YOU SUFFERED A LOSS ON YOUR INSPIRE MEDICAL SYSTEMS, INC. (INSP) INVESTMENTS, CLICK HERE TO SUBMIT A CLAIM TO POTENTIALLY RECOVER YOUR LOSSES IN THE ONGOING SECURITIES FRAUD LAWSUIT.

“Normally during sleep, your brain releases ADH (antidiuretic hormone) that tells your kidneys to CONSERVE water – so you can ...

Women with PCOS were less likely than women without PCOS to report changes to sleep patterns or quality after natural menopause.

LivaNova (Nasdaq: LIVN) today announced its new strategic roadmap and long-range financial plan at its 2025 Investor Day.

DexCom reported revenues of $1.21 billion, up 21.6% year on year. This print exceeded analysts’ expectations by 2.5%. Overall, it was a strong quarter for the company with a solid beat of analysts’ ...

After hospitals are acquired by private equity firms, patient deaths in the emergency room rise by roughly 13 percent, ...